Quince Therapeutics Inc. (QNCX)
NASDAQ: QNCX
· Real-Time Price · USD
1.93
-0.05 (-2.53%)
At close: Oct 16, 2025, 3:59 PM
1.90
-1.55%
After-hours: Oct 16, 2025, 07:15 PM EDT
-2.53% (1D)
| Bid | 1.9 |
| Market Cap | 103.67M |
| Revenue (ttm) | 168K |
| Net Income (ttm) | -49.03M |
| EPS (ttm) | -1.1 |
| PE Ratio (ttm) | -1.75 |
| Forward PE | -2.62 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.02 |
| Volume | 361,958 |
| Avg. Volume (20D) | 256,985 |
| Open | 1.97 |
| Previous Close | 1.98 |
| Day's Range | 1.90 - 2.04 |
| 52-Week Range | 0.72 - 2.45 |
| Beta | 1.08 |
| Ex-Dividend Date | n/a |
About QNCX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNCX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for QNCX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+19.17%
Quince Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
11 months ago
+19.5%
Quince Therapeutics shares are trading higher after the company reported a year-over-year increase in Q3 EPS results.
